The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.
Open accessAbstract
Neopterin, a compound derived from GTP, represents a precursor molecule of biopterin that is an essential cofactor in neurotransmitter synthesis. We have recently reported that in vivo as well as in vitro immune responses are accompanied by an increased release of neopterin and that this phenomenon can be used for the biochemical monitoring of diseases accompanied by hyperimmune stimulation. This article deals with the cellular origin and the control of this immune response-associated neopterin release in vitro. Using highly purified or monoclonal cellular reagents we demonstrate that macrophages (M phi) stimulated with supernatants from activated T cells release large amounts of neopterin into culture supernatants. Further experiments involving induction of neopterin release from M phi with various human recombinant interferons (IFNs) or neutralization of the effect of T cell supernatants with various monoclonal anti-IFN antibodies revealed immune IFN as the active principle. It thus appears that a metabolic pathway so far exclusively known in context with the generation of an essential cofactor of neurotransmitter-synthesis during immune responses is also activated in M phi under stringent control by immune IFN-like lymphokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte Interferon
Preble, O. T., Black, R. J., Friedman, R. M., Klippel, J. H., & Vilček, J. (1982) · Science · doi:10.1126/science.6176024 · Cited by 459
THE STRUCTURE OF THE PHENYLALANINE-HYDROXYLATION COFACTOR
Kaufman, S. (1963) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.50.6.1085 · Cited by 376
Acid-Labile Human Leukocyte Interferon in Homosexual Men with Kaposi's Sarcoma and Lymphadenopathy
DeStefano, E., Friedman, R. M., Friedman‐Kien, A. E., Goedert, J. J., Henriksen-DeStefano, D., Preble, O. T., SONNABEND, J. A., & Vilček, J. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/146.4.451 · Cited by 326
Hyperphenylalaninemia Due to a Deficiency of Biopterin: A Variant Form of Phenylketonuria
Kaufman, S., Berlow, S., Summer, G. K., Milstien, S., Schulman, J. D., Orloff, S., Spielberg, S., & Pueschel, S. (1978) · New England Journal of Medicine · doi:10.1056/nejm197809282991301 · Cited by 189
Huber, C. H., Fuchs, D., Hausen, A., Margreiter, R., Reibnegger, G. J., Spielberger, M., & WACHTER, H. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.3.1047 · Cited by 152
Self-citationDetermination of neopterine in human urine by reversed-phase high-performance liquid chromatography
Hausen, A., Fuchs, D., König, K., et al. (1982) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)80356-4 · Cited by 113
Self-citation
Cited by
Secretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615
Fahey, J. L., Taylor, J. M. G., Detels, R., Hofmann, B., Melmed, R., Nishanian, P., & Giorgi, J. V. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001183220305 · Cited by 1,023
Cytokine expression in the brain during the acquired immunodeficiency syndrome
Tyor, W. R., Glass, J. D., Griffin, J. W., Becker, P. S., McArthur, J. C., Bezman, L., & Griffin, D. E. (1992) · Annals of Neurology · doi:10.1002/ana.410310402 · Cited by 568
Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection
Fuchs, D., Hausen, A., Reibnegger, G., Werner, E. R., Dierich, M. P., & Wachter, H. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91203-0 · Cited by 563
Self-citationWeinberg, J., Misukonis, M., Shami, P., Mason, S., Sauls, D., Dittman, W., Wood, E., Smith, G., McDonald, B., & Bachus, K. (1995) · Blood · doi:10.1182/blood.v86.3.1184.1184 · Cited by 440
People with intellectual disability: What do we know about adulthood and life expectancy?
Coppus, A. M. W. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1123 · Cited by 374
Neopterin as Marker for Activation of Cellular Immunity: Immunologic Basis and Clinical Application
(1989) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(08)60182-1 · Cited by 373
Midttun, Ø., Hustad, S., & Ueland, P. M. (2009) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.4013 · Cited by 358
Antioxidants, inflammation and cardiovascular disease
Mangge, H. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i6.462 · Cited by 338
Biologic Rhythms in the Immune System
Haus, E., & Smolensky, M. H. (1999) · Chronobiology International · doi:10.3109/07420529908998730 · Cited by 338
Fuchs, D., Weiss, G., Reibnegger, G., & Wachter, H. (1992) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369209114604 · Cited by 326
Self-citationKosek, M., Haque, R., Lima, A., Babji, S., Shrestha, S., Qureshi, S., Amidou, S., Mduma, E., Lee, G., Yori, P. P., et al. (2013) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0549 · Cited by 326
Pterin-Dependent Amino Acid Hydroxylases
Kappock, T. J., & Caradonna, J. P. (1996) · Chemical Reviews · doi:10.1021/cr9402034 · Cited by 326
Erren, M., Reinecke, H., Junker, R., Fobker, M., Schulte, H., Schurek, J. O., Kropf, J., Kerber, S., Breithardt, G., Assmann, G., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2355 · Cited by 306
Maes, M., Scharpé, S., Meltzer, H. Y., Okayli, G., Bosmans, E., D'Hondt, P., Vanden Bossche, B., & Cosyns, P. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90003-5 · Cited by 302
Stein, D. S., Korvick, J. A., & Vermund, S. H. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.2.352 · Cited by 302
Zouridakis, E., Avanzas, P., Arroyo-Espliguero, R., Fredericks, S., & Kaski, J. C. (2004) · Circulation · doi:10.1161/01.cir.0000142664.18739.92 · Cited by 274
Tilg, H., van Montfrans, C., van den Ende, A., Kaser, A., van Deventer, S. J. H., Schreiber, S., Gregor, M., Ludwiczek, O., Rutgeerts, P., Gasche, C., et al. (2002) · Gut · doi:10.1136/gut.50.2.191 · Cited by 272
Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective
Park, B. K., Pirmohamed, M., & Kitteringham, N. R. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980058f · Cited by 267
Neopterin measurement in clinical diagnosis
Berdowska, A., & Zwirska-Korczala, K. (2001) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2001.00358.x · Cited by 256
Iron status and the outcome of HIV infection: an overview
Gordeuk, V. R., Delanghe, J. R., Langlois, M. R., & Boelaert, J. R. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00134-7 · Cited by 124
Iron Chelation Therapy for Malaria
Mabeza, G. F., Loyevsky, M., Gordeuk, V. R., & Weiss, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00037-0 · Cited by 111
Tetrahydrobiopterin, superoxide, and vascular dysfunction
Vásquez-Vivar, J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.024 · Cited by 84
“The GTPCH activity is increased at the transcriptional level by upregulating protein expression levels [28,29].”
Hoyo-Becerra, C., Huebener, A., Trippler, M., Lutterbeck, M., Liu, Z. J., Truebner, K., Bajanowski, T., Gerken, G., Hermann, D. M., & Schlaak, J. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083149 · Cited by 49
Interferon-alpha and its effects on the cytokine cascade: a pro- and anti-inflammatory cytokine
Tilg, H., & Peschel, C. (1996) · Leukemia & Lymphoma · doi:10.3109/10428199609054802 · Cited by 34
Zoller, H., Schloegl, A., Schroecksnadel, S., Vogel, W., & Fuchs, D. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0093 · Cited by 33
Self-citationBellmann-Weiler, R., Martinz, V., Kurz, K., Engl, S., Feistritzer, C., Fuchs, D., Rupp, J., Paldanius, M., & Weiss, G. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.021 · Cited by 27
Self-citationSchlaak, J. F., Trippler, M., Hoyo-Becerra, C., Erim, Y., Kis, B., Wang, B., Scherbaum, N., & Gerken, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038668 · Cited by 25
“Interestingly, it has already been shown that different IFN types, including pegylated-IFN forms, are able to induce GCH1 activation with the subsequent increase of BH4 and its precursor neopterin, released from monocytes and macrophages [54,55], which has been widely used as a pharmacodynamic marker in the evaluation…”
BackgroundScott, D. A., Poston, R. N., Wilson, R. F., Coward, P. Y., & Palmer, R. M. (2005) · Inflammation Research · doi:10.1007/s00011-004-1335-4 · Cited by 22
Wang, Y., Hu, G.-F., & Wang, Z. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s136259 · Cited by 21
“To estimate the IDO activity, the Kyn/Trp ratio was calculated.(83)”
Metadata
- Authors
- Huber, C., Batchelor, J. R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J., & Wachter, H.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1984-07-01
- Volume
- 160
- Issue
- 1
- Pages
- 310-316
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2165233139
- Cited by
- 1,084
- References
- 6
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.